Emclaire Financial (EMCF) Stock Alert: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Emclaire Financial Corp. Is Fair to Shareholders

Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Emclaire Financial Corp. (NASDAQ: EMCF) to Farmers National Banc Corp. is fair to Emclaire shareholders. Pursuant to the agreement, Emclaire shareholders may elect to receive either $40.00 per share in cash or 2.15 shares of Farmers’ common stock, subject to an overall limitation of 70% of the shares being exchanged for Farmers’ shares and 30% for cash.

Halper Sadeh encourages Emclaire shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com.

The investigation concerns whether Emclaire and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to, among other things: (1) obtain the best possible consideration for Emclaire shareholders; (2) determine whether Farmers is underpaying for Emclaire; and (3) disclose all material information necessary for Emclaire shareholders to adequately assess and value the merger consideration. On behalf of Emclaire shareholders, Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.

Halper Sadeh encourages Emclaire shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220324005878/en/